Levetiracetam versus carbamazepine monotherapy for partial epilepsy in children less than 16 years of age

Journal of Child Neurology

Volumn 23, Issue 5, 2008, Pages 515-519

  Perry, Scott ^a   Holt, Philip ^a   Benatar, Michael ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiepileptic drugs; Carbamazepine; Epilepsy; Levetiracetam; Partial seizures

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; ETIRACETAM; PHENOBARBITAL; PHENYTOIN;

ADOLESCENT; ARTICLE; BEHAVIOR; BENIGN CHILDHOOD EPILEPSY; CHILD; CLINICAL PROTOCOL; CONCENTRATION LOSS; CONTROLLED STUDY; DIZZINESS; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG ERUPTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOCAL EPILEPSY; FOLLOW UP; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MOOD; PRIORITY JOURNAL; SEIZURE; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE;

ANTICONVULSANTS; CARBAMAZEPINE; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; DRUG EVALUATION; EPILEPSIES, PARTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PIRACETAM; RETROSPECTIVE STUDIES;

EID: 42449098570     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073807309784     Document Type: Article

References (16)

1. Glauser T., Ben-Menachem E., Bourgeois B., et al. ILAE treatment guidelines: Evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2006; 47: 1094-1120.
2. Ben-Menachem E. Preliminary efficacy of levetiracetam in monotherapy. Epileptic Disord. 2003; 5 (suppl 1): S51-S55.
3. Connock M., Frew E., Evans BW, et al. The clinical effectiveness and cost-effectiveness of newer drugs for children with epilepsy. A systematic review. Health Technol Assess. 2006; 10: Iii, ix-118.
4. Ben-Menachem E., Falter U. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: A multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group. Epilepsia. 2000; 41: 1276-1283.
5. Brodie MJ, Perucca E., Ryvlin P., et al. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology. 2007;68: 402-408.
6. Cohen J. Levetiracetam monotherapy for primary generalized epilepsy. Seizure. 2003;12: 150-153.
7. Labate A., Colosimo E., Gambardella A., et al. Levetiracetam in patients with generalised epilepsy and myoclonic seizures: An open label study. Seizure. 2006; 15: 214-218.
8. Verotti A., Coppola G., Manco R., et al. Levetiracetam monotherapy for children and adolescents with benign rolandic seizures. Seizure. 2007; 16: 271-275.
9. Koukkari MW, Guarino EJ Retrospective study of the use of levetiracetam in childhood seizure disorders. J Child Neurol. 2004; 19: 944-947.
10. Khurana DS, Kothare SV, Valencia I., et al. Levetiracetam monotherapy in children with epilepsy. Pediatr Neurol. 2007; 36: 227-230.
11. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia. 1989; 30: 389-399.
12. Perry MS, Benatar M. Efficacy and tolerability of levetiracetam in children younger than 4 years: A retrospective review. Epilepsia. 2007; 48: 1123-1127.
13. Gustafson MC, Ritter FJ, Frost MD, et al. Behavioral and emotional effects of levetiracetam in children with intractable epilepsy. Epilepsia. 2002; 43 (suppl 7): 58. Abstract.
14. Kugler SL, Patel IM, Mandelbaum DE, et al. Behavioral profile of levetiracetam in children. Epilepsia. 2002; 43 (suppl 7): 59. Abstract.
15. Resendiz-Aparicio JC, Rodriguez-Rodriguez E., Contreras-Bernal J., et al. A randomized open trial comparing monotherapy with topiramate versus carbamazepine in the treatment of paediatric patients with recently diagnosed epilepsy. Rev Neurol. 2004; 39: 201-204.
16. Ficker DM, Privitera M., Krauss G., et al. Improved tolerability and efficacy in epilepsy patients with extended-release carbamazepine. Neurology. 2005; 65: 593-595.